2023, Clinical Research, Pharmacy and Testimonials

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog: Biosimilars

APRIL 8, 2024

pharmacy benefit managers (PBMs), group purchasing organizations (GPOs), wholesale distributors) play before a finished product ever makes it to a patient. We recently summarized another GAO report which described challenges FDA continues to face with clinical research inspections. Section I.C

Drugs

Drugs FDA Hospitals Government

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Agency IQ

OCTOBER 27, 2023

What We Expect the FDA to do in November 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA

FDA Science Regulations Production

Drug Discovery Digest

Does the Drug Shortage White Paper Fall Short?

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Stay Connected